ABEONA THERAPEUTICS INC. Capital Expenditures
ABEONA THERAPEUTICS INC. (ABEO) reported Capital Expenditures of $1.41 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- ABEONA THERAPEUTICS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $479.00K, a 83.49% decline year-over-year.
- ABEONA THERAPEUTICS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $935.00K, a 33.26% decline year-over-year.
- ABEONA THERAPEUTICS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $1.15M, a 90.26% increase year-over-year.
- ABEONA THERAPEUTICS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $2.52M, a 523.76% increase year-over-year.
- ABEONA THERAPEUTICS INC. payments to acquire property, plant, and equipment for fiscal 2025 was $7.97M, a 226.04% increase from fiscal 2024.
- ABEONA THERAPEUTICS INC. payments to acquire property, plant, and equipment for fiscal 2024 was $2.45M, a 638.97% increase from fiscal 2023.
- ABEONA THERAPEUTICS INC. payments to acquire property, plant, and equipment for fiscal 2023 was $331.00K, a 154.62% increase from fiscal 2022.
- ABEONA THERAPEUTICS INC. payments to acquire property, plant, and equipment for fiscal 2022 was $130.00K, a 96.87% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $479.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.41M 10-Q · filed 2026-08-13 | $2.57M derived: sum of 3 quarters · filed 2026-08-13 | $5.09M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $935.00K 10-Q · filed 2026-05-13 | $2.09M derived: sum of 2 quarters · filed 2026-05-13 | $4.61M derived: sum of 3 quarters · filed 2026-05-13 | $7.51M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $3.67M derived: sum of 2 quarters · filed 2026-03-17 | $6.57M derived: sum of 3 quarters · filed 2026-08-13 | $7.97M 10-K · filed 2026-03-17 |
| 2025-09-30 | $2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $5.42M derived: sum of 2 quarters · filed 2026-08-13 | $6.82M 10-Q · filed 2025-11-12 | $7.43M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $4.30M 10-Q · filed 2026-08-13 | $4.91M derived: sum of 3 quarters · filed 2026-08-13 | $5.31M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.40M 10-Q · filed 2026-05-13 | $2.01M derived: sum of 2 quarters · filed 2026-05-13 | $2.41M derived: sum of 3 quarters · filed 2026-05-13 | $3.12M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $606.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $1.01M derived: sum of 2 quarters · filed 2026-03-17 | $1.72M derived: sum of 3 quarters · filed 2026-03-17 | $2.45M 10-K · filed 2026-03-17 |
| 2024-09-30 | $404.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.11M derived: sum of 2 quarters · filed 2025-11-12 | $1.84M 10-Q · filed 2025-11-12 | $1.88M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $711.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.44M 10-Q · filed 2025-08-14 | $1.47M derived: sum of 3 quarters · filed 2025-08-14 | $1.52M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $725.00K 10-Q · filed 2025-05-15 | $762.00K derived: sum of 2 quarters · filed 2025-05-15 | $806.00K derived: sum of 3 quarters · filed 2025-05-15 | $838.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $81.00K derived: sum of 2 quarters · filed 2025-03-20 | $113.00K derived: sum of 3 quarters · filed 2025-03-20 | $331.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $76.00K derived: sum of 2 quarters · filed 2024-11-14 | $294.00K 10-Q · filed 2024-11-14 | $319.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $250.00K 10-Q · filed 2024-08-12 | $275.00K derived: sum of 3 quarters · filed 2024-08-12 | $277.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $218.00K 10-Q · filed 2024-05-15 | $243.00K derived: sum of 2 quarters · filed 2024-05-15 | $245.00K derived: sum of 3 quarters · filed 2024-05-15 | $245.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $27.00K derived: sum of 2 quarters · filed 2024-03-18 | $27.00K derived: sum of 3 quarters · filed 2024-03-18 | $130.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.00K derived: sum of 2 quarters · filed 2023-11-13 | $105.00K 10-Q · filed 2023-11-13 | $3.35M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $103.00K 10-Q · filed 2023-08-08 | $3.35M derived: sum of 3 quarters · filed 2023-08-08 | $3.75M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $103.00K 10-Q · filed 2023-05-11 | $3.35M derived: sum of 2 quarters · filed 2023-05-11 | $3.75M derived: sum of 3 quarters · filed 2023-05-11 | $3.81M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $3.65M derived: sum of 2 quarters · filed 2023-03-29 | $3.71M derived: sum of 3 quarters · filed 2023-03-29 | $4.15M 10-K · filed 2023-03-29 |
| 2021-09-30 | $402.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $459.00K derived: sum of 2 quarters · filed 2022-11-14 | $903.00K 10-Q · filed 2022-11-14 | $936.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $501.00K 10-Q · filed 2022-08-11 | $534.00K derived: sum of 3 quarters · filed 2022-08-11 | $805.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $444.00K 10-Q · filed 2022-05-13 | $477.00K derived: sum of 2 quarters · filed 2022-05-13 | $748.00K derived: sum of 3 quarters · filed 2022-05-13 | $1.30M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $304.00K derived: sum of 2 quarters · filed 2022-03-31 | $857.00K derived: sum of 3 quarters · filed 2022-03-31 | $1.34M 10-K · filed 2022-03-31 |
| 2020-09-30 | $271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $824.00K derived: sum of 2 quarters · filed 2021-11-15 | $1.30M 10-Q · filed 2021-11-15 | $1.43M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $553.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $1.03M 10-Q · filed 2021-07-28 | $1.15M derived: sum of 3 quarters · filed 2021-07-28 | $2.09M derived: sum of 4 quarters · filed 2021-07-28 |
| 2020-03-31 | $479.00K 10-Q · filed 2021-05-17 | $601.00K derived: sum of 2 quarters · filed 2021-05-17 | $1.54M derived: sum of 3 quarters · filed 2021-05-17 | $5.56M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $1.06M derived: sum of 2 quarters · filed 2021-03-24 | $5.08M derived: sum of 3 quarters · filed 2021-03-24 | $6.31M 10-K · filed 2021-03-24 |
| 2019-09-30 | $937.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $4.96M derived: sum of 2 quarters · filed 2020-11-09 | $6.19M 10-Q · filed 2020-11-09 | $6.85M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $4.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $5.25M 10-Q · filed 2020-08-10 | $5.91M derived: sum of 3 quarters · filed 2020-08-10 | $7.57M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $1.23M 10-Q · filed 2020-05-06 | $1.89M derived: sum of 2 quarters · filed 2020-05-06 | $3.55M derived: sum of 3 quarters · filed 2020-05-06 | $6.97M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $663.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $2.32M derived: sum of 2 quarters · filed 2020-03-16 | $5.74M derived: sum of 3 quarters · filed 2020-03-16 | $9.24M 10-K · filed 2020-03-16 |
| 2018-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $5.08M derived: sum of 2 quarters · filed 2019-11-12 | $8.58M 10-Q · filed 2019-11-12 | $9.28M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | $3.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $6.92M 10-Q · filed 2019-08-09 | $7.63M derived: sum of 3 quarters · filed 2020-03-16 | $7.70M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | $3.50M 10-Q · filed 2019-05-10 | $4.21M derived: sum of 2 quarters · filed 2020-03-16 | $4.28M derived: sum of 3 quarters · filed 2020-03-16 | $4.29M derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $704.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $776.00K derived: sum of 2 quarters · filed 2020-03-16 | $786.00K derived: sum of 3 quarters · filed 2020-03-16 | $860.00K 10-K · filed 2020-03-16 |
| 2017-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $82.00K derived: sum of 2 quarters · filed 2018-11-09 | $156.00K 10-Q · filed 2018-11-09 | $174.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $84.00K 10-Q · filed 2018-08-09 | $102.00K derived: sum of 3 quarters · filed 2019-03-18 | $250.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | $74.00K 10-Q · filed 2018-05-10 | $92.00K derived: sum of 2 quarters · filed 2019-03-18 | $240.00K derived: sum of 3 quarters · filed 2019-03-18 | $366.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $166.00K derived: sum of 2 quarters · filed 2019-03-18 | $292.00K derived: sum of 3 quarters · filed 2019-03-18 | $519.00K 10-K · filed 2019-03-18 |
| 2016-09-30 | $148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $274.00K derived: sum of 2 quarters · filed 2017-11-14 | $501.00K 10-Q · filed 2017-11-14 | $768.00K derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $353.00K 10-Q · filed 2017-08-14 | $620.00K derived: sum of 3 quarters · filed 2017-08-14 | $647.00K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $227.00K 10-Q · filed 2017-05-15 | $494.00K derived: sum of 2 quarters · filed 2017-05-15 | $521.00K derived: sum of 3 quarters · filed 2017-05-15 | $526.00K derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $294.00K derived: sum of 2 quarters · filed 2017-03-30 | $299.00K derived: sum of 3 quarters · filed 2017-03-30 | $308.00K 10-K · filed 2017-03-30 |
| 2015-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $32.00K derived: sum of 2 quarters · filed 2016-11-14 | $41.00K 10-Q · filed 2016-11-14 | $41.00K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $14.00K 10-Q · filed 2016-08-15 | $14.00K derived: sum of 3 quarters · filed 2016-08-15 | $14.00K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | $9.00K 10-Q · filed 2016-05-16 | $9.00K derived: sum of 2 quarters · filed 2016-05-16 | $9.00K derived: sum of 3 quarters · filed 2016-05-16 | $9.00K derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | $0.00 derived: sum of 3 quarters · filed 2016-03-30 | $0.00 10-K · filed 2016-03-30 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $0.00 derived: sum of 2 quarters · filed 2015-11-16 | $0.00 10-Q · filed 2015-11-16 | $1.00K derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $0.00 10-Q · filed 2015-08-14 | $1.00K derived: sum of 3 quarters · filed 2015-08-14 | $2.00K derived: sum of 4 quarters · filed 2015-08-14 |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-14 | $1.00K derived: sum of 2 quarters · filed 2015-05-14 | $2.00K derived: sum of 3 quarters · filed 2015-05-14 | $2.00K derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $2.00K derived: sum of 2 quarters · filed 2015-03-31 | $2.00K derived: sum of 3 quarters · filed 2015-03-31 | $2.00K 10-K · filed 2015-03-31 |
| 2013-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $1.00K derived: sum of 2 quarters · filed 2014-11-14 | $1.00K 10-Q · filed 2014-11-14 | -$1.00K derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | -$2.00K derived: sum of 3 quarters · filed 2014-03-26 | -$2.00K derived: sum of 4 quarters · filed 2014-03-26 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-15 | -$2.00K derived: sum of 2 quarters · filed 2014-03-26 | -$2.00K derived: sum of 3 quarters · filed 2014-03-26 | $0.00 derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$2.00K derived: sum of 2 quarters · filed 2014-03-26 | $0.00 derived: sum of 3 quarters · filed 2014-03-26 | $13.00K 10-K · filed 2014-03-26 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $2.00K derived: sum of 2 quarters · filed 2013-11-14 | $15.00K 10-Q · filed 2013-11-14 | $15.00K derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $15.00K 10-Q · filed 2013-08-14 | $15.00K derived: sum of 3 quarters · filed 2013-08-14 | $16.00K derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $13.00K 10-Q · filed 2013-05-15 | $13.00K derived: sum of 2 quarters · filed 2013-05-15 | $14.00K derived: sum of 3 quarters · filed 2013-05-15 | $31.00K derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | $1.00K derived: sum of 2 quarters · filed 2013-03-20 | $18.00K derived: sum of 3 quarters · filed 2013-03-20 | $40.00K 10-K · filed 2013-03-20 |
| 2011-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $18.00K derived: sum of 2 quarters · filed 2012-11-14 | $40.00K 10-Q · filed 2012-11-14 | $40.00K derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $39.00K 10-Q · filed 2012-08-14 | $39.00K derived: sum of 3 quarters · filed 2012-08-14 | $38.00K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $22.00K 10-Q · filed 2012-05-15 | $22.00K derived: sum of 2 quarters · filed 2012-05-15 | $21.00K derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-23 | -$1.00K derived: sum of 2 quarters · filed 2012-03-23 | $7.00K 10-K · filed 2012-03-23 | |
| 2010-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $7.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $8.00K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |